Physiopathology of the embryonic heart (with special emphasis on hypoxia and reoxygenation)

Annales de Cardiologie et d'Angeiologie

Volumn 55, Issue 2, 2006, Pages 79-89

  Raddatz, E ^a   Gardier, S ^a   Sarre, A ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Embryonic; Heart; Physiopathology

Indexed keywords

CALCIUM; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; SODIUM; OXYGEN;

ANOXIA; APOPTOSIS; ARTICLE; CELL SURVIVAL; DEATH; EMBRYO DEVELOPMENT; ENERGY METABOLISM; HEART ARRHYTHMIA; HEART DISEASE; HEART FUNCTION; HEART MUSCLE; HEART SURGERY; HYPOXIA; NONHUMAN; OXIDATIVE STRESS; OXYGEN TRANSPORT; REOXYGENATION; SIGNAL TRANSDUCTION; ANIMAL; CELL HYPOXIA; HEART; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PRENATAL DEVELOPMENT; REVIEW;

ANIMALS; CELL HYPOXIA; ENERGY METABOLISM; HEART; HUMANS; MYOCARDIUM; OXYGEN;

EID: 33747758417     PISSN: 00033928     EISSN: 17683181     Source Type: Journal    
DOI: 10.1016/j.ancard.2006.02.007     Document Type: Article

References (152)

1. Brette F., and Orchard C. T-tubule function in mammalian cardiac myocytes. Circ. Res. 92 (2003) 1182-1192
2. Männer J. Cardiac looping in the chick embryo: a morphological review with special reference to terminological and biomechanical aspects of the looping process. Anat. Rec. 259 (2000) 248-262
3. Moorman A.F.M., and Christoffels V.M. Cardiac chamber formation: development, genes, and evolution. Physiol. Rev. 83 (2003) 1223-1267
4. Reckova M., Rosengarten C., deAlmeida A., Stanley C.P., Wessels A., Gourdie R.G., et al. Hemodynamics is a key epigenetic factor in development of the cardiac conduction system. Circ. Res. 93 (2003) 77-85
5. Hamburger V., and Hamilton H.L. A series of normal stages in the development of the chick embryo. J. Morphol. 88 (1951) 49-92
6. Tomanek R.J., and Ratajska A. Vasculogenesis and angiogenesis in the developing heart. In: Burggren W.W., and Keller B.B. (Eds). Development of Cardiovascular Systems. Molecules to Organisms (1997), Cambridge University Press, Cambridge 35-42
7. Reese D.E., Mikawa T., and Bader D.M. Development of the coronary vessel system. Circ. Res. 91 (2002) 761-768
8. Olivey H.E., Compton L.A., and Barnett J.V. Coronary vessel development-the epicardium delivers. Trends Cardiovasc. Med. 14 (2004) 247-251
9. Martinsen B.J. Reference guide to the stages of chick heart embryology. Dev. Dyn. 233 (2005) 1217-1237
10. Semenza G.L., Agani F., Iyer N., Kotch L., Laughner E., Leung S., et al. Regulation of cardiovascular development and physiology by hypoxia-inducible factor 1 α. Ann. N. Y. Acad. Sci. 874 (1999) 262-268
11. Sugishita Y., Leifer D.W., Agani F., Watanabe M., and Fisher S.A. Hypoxia-responsive signaling regulates the apoptosis-dependent remodeling of the embryonic avian cardiac outflow tract. Dev. Biol. 273 (2004) 285-296
12. Catron T., Mendiola M.A., Smith S.M., Born J., and Walker M.K. Hypoxia regulates avian cardiac Arnt and HIF-1alpha mRNA expression. Biochem. Biophys. Res. Commun. 282 (2001) 602-607
13. Lee Y.M., Jeong C.-H., Koo S.-Y., Son M.J., Song H.S., Bae S.-K., et al. Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: a possible signal for vessel development. Dev. Dyn. 220 (2001) 175-186
14. Burggren W.W., Warburton S.J., and Slivkoff M.D. Interruption of cardiac output does not affect short-term growth and metabolic rate in day 3 and 4 chick embryos. J. Exp. Biol. 203 (2000) 3831-3838
15. Romano R., Rochat A.-C., Kucera P., de Ribaupierre Y., and Raddatz E. Oxidative and glycogenolytic capacities within the developing chick heart. Pediatr. Res. 49 (2001) 363-372
16. Hu N., and Clark E.B. Hemodynamics of the stage 12 to stage 29 chick embryo. Circ. Res. 65 (1989) 1665-1670
17. Raddatz E., Servin M., and Kucera P. Oxygen uptake during early cardiogenesis of the chick. Am. J. Physiol. 262 (1992) H1224-H1230
18. Raddatz E., Kucera P., and de Ribaupierre Y. Response of the embryonic heart to hypoxia and reoxygenation: an in vitro model. Exp. Clin. Cardiol. 2 (1997) 128-134
19. Tenthorey D., de Ribaupierre Y., Kucera P., and Raddatz E. Effects of verapamil and ryanodine on activity of the embryonic chick heart during anoxia and reoxygenation. J. Cardiovasc. Pharmacol. 31 (1998) 195-202
20. Budinger G.R.S., Chandel N., Shao Z.H., Li C.Q., Melmed A., Becker L.B., et al. Cellular energy utilization and supply during hypoxia in embryonic cardiac myocytes. Am. J. Physiol. 270 (1996) L44-L53
21. Seltzer J.L., and McDougal Jr. D.B. Enzyme levels in chick embryo heart and brain from 1 to 21 days of development. Dev. Biol. 42 (1975) 95-105
22. Tuganowski W., Samek D., and Glenc F. Glycogen content in human embryonic heart. In: Roy P.-E., and Harris P. (Eds). The Cardiac Sarcoplasm (1975), University Park Press, Baltimore 179-180
23. Tran L., Kucera P., de Ribaupierre Y., Rochat A.-C., and Raddatz E. Glucose is arrhythmogenic in the anoxic-reoxygenated embryonic chick heart. Pediatr. Res. 39 (1996) 766-773
24. Sedmera D., Kucera P., and Raddatz E. Developmental changes in cardiac recovery from anoxia-reoxygenation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283 (2002) R379-R388
25. Sarre A., Lange N., Kucera P., and Raddatz E. MitoKATP channel activation in the postanoxic developing heart protects E-C coupling via NO-,ROS-, and PKC-dependent pathways. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) 1611-1619
26. Lopaschuk G.D., Collins-Nakai R.L., and Itoi T. Developmental changes in energy substrate use by the heart. Cardiovasc. Res. 26 (1992) 1172-1180
27. Smoak I.W., and Branch S. Glut-1 expression and its response to hypoglycemia in the embryonic mouse heart. Anat. Embryol. (Berl.) 201 (2000) 327-333
28. Marin-Garcia J. Mitochondria in pediatric cardiology. In: Marin-Garcia J. (Ed). Mitochondria and the Heart (2005), Springer, New York 229-261
29. Rouwet E.V., Tintu A.N., Schellings M.W.M., Van Bilsen M., Lutgens E., Hofstra L., et al. Hypoxia induces aortic hypertrophic growth, left ventricular dysfunction, and sympathetic hyperinnervation of peripheral arteries in the chick embryo. Circulation 105 (2002) 2791-2796
30. Sharma S.K., Lucitti J.L., Nordman C., Tinney J.P., Tobita K., and Keller B.B. Impact of hypoxia on early chick embryo growth and cardiovascular function. Pediatr. Res. 59 (2006) 116-120
31. Villamor E., Kessels C.G.A., Ruijtenbeek K., van Suylen R.J., Belik J., De Mey J.G.R., et al. Chronic in ovo hypoxia decreases pulmonary arterial contractile reactivity and induces biventricular cardiac enlargement in the chicken embryo. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287 (2004) R642-R651
32. Ruijtenbeek K., Kessels C.G.A., Janssen B.J.A., Bitsch N.J.J.E., Fazzi G.E., Janssen G.M.J., et al. Chronic moderate hypoxia during in ovo development alters arterial reactivity in chickens. Pflügers Arch. Eur. J. Physiol. 447 (2003) 158-167
33. Mancini L., Bertossi M., Ribatti D., Bartoli F., Nico B., Lozupone E., et al. The effects of long-term hypoxia on epicardium and myocardium in developing chick embryo hearts. Int. J. Microcirc. Clin. Exp. 10 (1991) 359-371
34. Akiyama R., Mitsubayashi H., Tazawa H., and Burggren W.W. Heart rate responses to altered ambient oxygen in early (days 3-9) chick embryos in the intact egg. J. Comp. Physiol. [B] 169 (1999) 85-92
35. Quaife R.A., Kohmoto O., and Barry H. Mechanisms of reoxygenation injury in cultured ventricular myocytes. Circulation 83 (1991) 566-577
36. Paff G.H., Boucek R.J., and Harrell T.C. Observations on the development of the electrocardiogram. Anat. Rec. 160 (1968) 575-582
37. Rosa A., Maury P., Terrand J., Lyon X., Kucera P., Kappenberger L., et al. Ectopic pacing at physiological rate improves postanoxic recovery of the developing heart. Am. J. Physiol. Heart Circ. Physiol. 284 (2003) H2384-H2392
38. Arguello C., Alanis J., Pantoja O., and Valenzuela B. Electrophysiological and ultrastructural study of the atrioventricular canal during the development of the embryo. J. Mol. Cell. Cardiol. 18 (1986) 499-510
39. Moorman A.F.M., Schumacher C.A., De Boer P.A.J., Hagoort J., Bezstarosti K., van den Hoff M.J.B., et al. Presence of functional sarcoplasmic reticulum in the developing heart and its confinement to chamber myocardium. Dev. Biol. 223 (2000) 279-290
40. Franco D., Gallego A., Habets P.E.M.H., Coma V.S., and Moorman A.F.M. Species-specific differences of myosin content in the developing cardiac chambers of fish, birds, and mammals. Anat. Rec. 268 (2002) 27-37
41. Franco D., Lamers W.H., and Moorman A.F.M. Patterns of expression in the developing myocardium: towards a morphologically integrated transcriptional model. Cardiovasc. Res. 38 (1998) 25-53
42. Alanis J., Argüello C., and Polo L. Effects of heparin on the electrophysiological and mechanical properties of early embryonic chick hearts. J. Mol. Cell. Cardiol. 29 (1997) 2503-2511
43. de Jong F., Opthof T., Wilde A.A.M., Janse M.J., Charles R., Lamers W.H., et al. Persisting zones of slow impulse conduction in developing chicken hearts. Circ. Res. 71 (1992) 240-250
44. Shrier A., and Clay J.R. Comparison of the pacemaker properties of chick embryonic atrial and ventricular heart cells. J. Membr. Biol. 69 (1982) 49-56
45. Liang B.T. Adenosine receptors and cardiovascular function. Trends Cardiovasc. Med. 2 (1992) 100-108
46. Porter G.A., and Rivkees S.A. Ontogeny of humoral heart rate regulation in the embryonic mouse. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281 (2001) R401-R407
47. Terrand J., Felley-Bosco E., Courjault-Gautier F., Rochat A.-C., Kucera P., and Raddatz E. Postanoxic functional recovery of the developing heart is slightly altered by endogenous or exogenous nitric oxide. Mol. Cell. Biochem. 252 (2003) 53-63
48. Maury P., Sarre A., Terrand J., Rosa A., Kucera P., Kappenberger L., et al. Ventricular but not atrial electro-mechanical delay of the embryonic heart is altered by anoxia-reoxygenation and improved by nitric oxide. Mol. Cell. Biochem. 265 (2004) 141-149
49. Van den Hoff M.J.B., Van den Eijnde S.M., Viragh S., and Moorman A.F.M. Programmed cell death in the developing heart. Cardiovasc. Res. 45 (2000) 603-620
50. Poelmann R.E., Molin D., Wisse L.J., Gittenberger-de Groot A.C., and Groot G.D. Apoptosis in cardiac development. Cell Tissue Res. 301 (2000) 43-52
51. Ren J., Zhang S., Kovacs A., Wang Y., and Muslin A.J. Role of p38alpha MAPK in cardiac apoptosis and remodeling after myocardial infarction. J. Mol. Cell. Cardiol. 38 (2005) 617-623
52. Coles J.G., Boscarino C., Takahashi M., Grant D., Chang A., Ritter J., et al. Cardioprotective stress response in the human fetal heart. J. Thorac. Cardiovasc. Surg. 129 (2005) 1128-1136
53. 2+ signalling in cardiogenesis. Cell Calcium 38 (2005) 383-389
54. 2+ channels and the sarcoplasmic reticulum. Am. J. Physiol. 270 (1996) H518-H525
55. Murphy J.G., Smith T.W., and Marsh J.D. Mechanisms of reoxygenation-induced calcium overload in cultured chick embryo heart cells. Am. J. Physiol. 254 (1988) H1133-H1141
56. Piper H.M., Garcia-Dorado D., and Ovize M. A fresh look at reperfusion injury. Cardiovasc. Res. 38 (1998) 291-300
57. Liu S., Piwnica-Worms D., and Lieberman M. Intracellular pH regulation in cultured embryonic chick heart cells. J. Gen. Physiol. 96 (1990) 1247-1269
58. Bhatti S., Zimmer G., and Bereiter-Hahn J. Enzyme release from chick myocytes during hypoxia and reoxygenation: dependence on pH. J. Mol. Cell. Cardiol. 21 (1989) 995-1008
59. Meiltz A., Kucera P., de Ribaupierre Y., and Raddatz E. Inhibition of bicarbonate transport protects embryonic heart against reoxygenation-induced dysfunction. J. Mol. Cell. Cardiol. 30 (1998) 327-335
60. Raddatz E., and Rochat A.-C. Heterogeneity of oxidant stress in the reoxygenated developing heart. J. Mol. Cell. Cardiol. 34 6 (2002) A52 (abstract)
61. Shao Z.-H., Li C.-Q., Vanden Hoek T.L., Becker L.B., Schumacker P.T., Wu J.A., et al. Extract from scutellaria baicalensis georgi attenuates oxidant stress in cardiomyocytes. J. Mol. Cell. Cardiol. 31 (1999) 1885-1895
62. Becker L.B., Vanden Hoek T.L., Shao Z.-H., Li C.-Q., and Schumacker P.T. Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am. J. Physiol. 277 (1999) H2240-H2246
63. Vanden Hoek T.L., Shao Z., Li C., Schumacker P.T., and Becker L.B. Mitochondrial electron transport can become a significant source of oxidative injury in cardiomyocytes. J. Mol. Cell. Cardiol. 29 (1997) 2441-2450
64. Vanden Hoek T.L., Li C., Shao Z., Schumacker P.T., and Becker L.B. Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J. Mol. Cell. Cardiol. 29 (1997) 2571-2583
65. Xu Z.L., Cohen M.V., Downey J.M., Vanden Hoek T.L., and Yao Z.H. Attenuation of oxidant stress during reoxygenation by AMP 579 in cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 281 (2001) H2585-H2589
66. Duranteau J., Chandel N.S., Kulisz A., Shao Z., and Schumacker P.T. Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J. Biol. Chem. 273 (1998) 11619-11624
67. Raddatz E., Tenthorey D., Tran L., Bender G., Kucera P., and de Ribaupierre Y. Protection of the embryonic heart during anoxia and reoxygenation. J. Mol. Cell. Cardiol. 26 (1994) (XCIX-P411 (abstract)
68. Raddatz E., Rochat A.-C., Mariethoz C., Kucera P., and Sedmera D. Lactate enhances oxidative stress in reoxygenated embryonic myocardium. J. Mol. Cell. Cardiol. 31 (1999) A53 (abstract)
69. Allen R.G. Oxygen-reactive species and antioxidant responses during development: The metabolic paradox of cellular differentiation. Proc. Soc. Exp. Biol. Med. 196 (1991) 117-129
70. Lebovitz R.M., Zhang H., Vogel H., Cartwright J., Dionne L., Lu N., et al. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc. Natl. Acad. Sci. USA 93 (1996) 9782-9787
71. Mover H., and Ar A. Antioxidant enzymatic activity in embryos and placenta of rats chronically exposed to hypoxia and hyperoxia. Comp. Biochem. Physiol. 117C (1997) 151-157
72. Tan S., Liu Y.-Y., Nielsen V.G., Skinner K., Kirk K.A., Baldwin S.T., et al. Maternal infusion of antioxidants (Trolox and ascorbic acid) protects the fetal heart in rabbit fetal hypoxia. Pediatr. Res. 39 (1996) 499-503
73. Surai P., Noble R.C., and Speake B.K. Tissue-specific differences in antioxidant distribution and susceptibility to lipid peroxidation during development of the chick embryo. Biochim. Biophys. Acta 1304 (1996) 1-10
74. Kobayashi M., Nakamura H., Yodoi J., and Shiota K. Immunohistochemical localization of thioredoxin and glutaredoxin in mouse embryos and fetuses. Antioxidants and Redox Signaling 2 (2000) 653-663
75. Southworth R., Shattock M.J., and Kelly F.J. Age-related differences in the cardiac response to ischemia and free radical production on perfusion. In: Ost'adal B., et al. (Ed). The Developing Heart (1997), Lippincott-Raven, Philadelphia 427-441
76. Wittnich C., Peniston C., Ianuzzo D., Abel J.G., and Salerno T.A. Relative vulnerability of neonatal and adult hearts to ischemic injury. Circulation 76 (1987) V156-V160
77. Wittnich C., and Torrance S.M. Does the severity of acute hypoxia influence neonatal myocardial metabolism and sensitivity to ischemia?. J. Mol. Cell. Cardiol. 26 (1994) 675-682
78. Otani H., Engelman R.M., Rousou J.A., Lemeshow S., and Das D.K. The mechanism of myocardial reperfusion injury in neonates. Circulation 76 suppl V (1987) 161-167
79. Fantel A.G., and Person R.E. Involvement of mitochondria and other free radical sources in normal and abnormal fetal development. Ann. N. Y. Acad. Sci. 959 (2002) 424-433
80. Cheng G., Cao Z., Xu X., Van Meir E.G., and Lambeth J.D. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269 (2001) 131-140
81. Radice S., Rossoni G., Oriani G., Michael M., Chiesara E., and Berti F. Hyperbaric oxygen worsens myocardial low flow ischemia-reperfusion injury in isolated rat heart. Eur. J. Pharmacol. 320 (1997) 43-49
82. Wittnich C. Postnatal development: metabolic and functional determinants of response to oxygen stress. In: Os'adal B., et al. (Ed). The Developing Heart (1997), Lippincott-Raven, Philadelphia 443-457
83. Fantel A.G. Reactive oxygen species in developmental toxicity: review and hypothesis. Teratology 53 (1996) 196-217
84. 2. Eur. J. Cardiothorac. Surg. 9 (1995) 410-418
85. Morita K., Ihnken K., and Buckberg G.D. Studies of hypoxemic/reoxygenation injury: with aortic clamping. XII. Delay of cardiac reoxygenation damage in the presence of cyanosis : A new concept of controlled cardiac reoxygenation. J. Thorac. Cardiovasc. Surg. 110 (1995) 1265-1273
86. Ihnken K. Myocardial protection in hypoxic immature hearts. Thorac. Cardiov. Surg. 48 (2000) 46-54
87. Del Nido P.J., Nakamura H., Mickle D.A.G., Illes R.W., Romaschin A., and Levitsky S. Maturational difference in functional/metabolic sequelae of free radical formation on reperfusion. J. Surg. Res. 46 (1989) 532-536
88. Castaneda A.R., Jonas R.A., Mayer J.E., and Hanley F.L. Myocardial preservation in the immature heart. Cardiac Surgery of the Neonate and Infant (1994), W.B. Saunders Company, Philadelphia 41-53
89. Malhotra S.P., Thelitz S., Riemer R.K., Reddy V.M., Suleman S., and Hanley F.L. Fetal myocardial protection is markedly improved by reduced cardioplegic calcium content. Ann. Thorac. Surg. 75 (2003) 1937-1941
90. Allen B.S. Fetal cardiac surgery: Simplicity versus success in a new frontier. J. Thorac. Cardiovasc. Surg. 126 (2003) 1254-1256
91. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
92. Ostadal B., Ostadalova I., and Dhalla N.S. Development of cardiac sensitivity to oxygen deficiency: comparative and ontogenetic aspects. Physiol. Rev. 79 (1999) 635-659
93. Ostadalova I., Ostadal B., Kolar F., Parratt J.R., and Wilson S. Tolerance to ischaemia and ischaemic preconditioning in neonatal rat heart. J. Mol. Cell. Cardiol. 30 (1998) 857-865
94. Bartling B., Friedrich I., Silber R.E., and Simm A. Ischemic preconditioning is not cardioprotective in senescent human myocardium. Ann. Thorac. Surg. 76 (2003) 105-111
95. Lyon X., Kappenberger L., Sedmera D., Rochat A.-C., Kucera P., and Raddatz E. Pacing redistributes glycogen within the developing myocardium. J. Mol. Cell. Cardiol. 33 (2001) 513-520
96. Lyon X., Kappenberger L., Kucera P., Rochat A.-C., and Raddatz E. Reduction of free radicals production at reoxygenation after anoxia in chronically paced embryonic chick heart. J. Am. Coll. Cardiol. 37 2 (2001) 116A (abstract)
97. Massion P.B., Feron O., Dessy C., and Balligand J.L. Nitric oxide and cardiac function-ten years after, and continuing. Circ. Res. 93 (2003) 388-398
98. Hare J.M. Nitric oxide and excitation-contraction coupling. J. Mol. Cell. Cardiol. 35 (2003) 719-729
99. Gouge R.C., Marshburn P., Gordon B.E., Nunley W., and Huet-Hudson Y.M. Nitric oxide as a regulator of embryonic development. Biol. Reprod. 58 (1998) 875-879
100. Bloch W., Fleischmann B.K., Lorke D.E., Hops B., Hescheler J., and Addicks K. Nitric oxide synthase expression and role during cardiomyogenesis. Cardiovasc. Res. 43 (1999) 675-684
101. Malan D., Ji G., Schmidt A., Addicks K., Hescheler J., Levi R.C., et al. Nitric oxide, a key signaling molecule in the murine early embryonic heart. FASEB J. (2004) 1-22
102. 2+ channel during cardiomyogenesis: switch from NO to adenylyl cyclase-mediated inhibition. FASEB J. 13 (1999) 313-324
103. Tohse N., and Sperelakis N. cGMP inhibits the activity of single calcium channels in embryonic chick heart cells. Circ. Res. 69 (1991) 325-331
104. Haddad G.E., Sperelakis N., and Bkaily G. Regulation of the calcium slow chanel by cyclic GMP dependent protein kinase in chick heart cells. Mol. Cell. Biochem. 148 (1995) 89-94
105. Ungureanu-Longrois D., Bézie Y., Perret C., and Laurent S. Effects of exogenous and endogenous nitric oxide on the contractile function of cultured chick embryo ventricular myocytes. J. Mol. Cell. Cardiol. 29 (1997) 677-687
106. Shimizu T., Kinugawa K.-I., Sugishita Y., Sugishita K., Harada K., Matsui H., et al. Molecular cloning and expression of inducible nitric oxide synthase in chick embryonic ventricular myocytes. Cardiovasc. Res. 38 (1998) 405-413
107. Stefanelli C., Pignatti C., Tantini B., Stanic I., Bonavita F., Muscari C., et al. Nitric oxide can function as either a killer molecule or an antiapoptotic effector in cardiomyocytes. Biochim. Biophys. Acta 1450 (1999) 406-413
108. Manasek F.J. Myocardial cell death in the embryonic chick ventricle. J. Embryol. Exp. Morphol. 21 (1969) 271-284
109. Kajstura J., Mansukhani M., Cheng W., Reiss K., Krajewski S., Reed J.C., et al. Programmed cell death and expression of the protooncogene bcl-2 in myocytes during postnatal maturation of the heart. Exp. Cell Res. 219 (1995) 110-121
110. Cheng G., Wessels A., Gourdie R.G., and Thompson R.P. Spatiotemporal and tissue specific distribution of apoptosis in the developing chick heart. Dev. Dyn. 223 (2002) 119-133
111. Maejima Y., Adachi S., Ito H., Nobori K., Tamamori-Adachi M., and Isobe M. Nitric oxide inhibits ischemia/reperfusion-induced myocardial apoptosis by modulating cyclin A-associated kinase activity. Cardiovasc. Res. 59 (2003) 308-320
112. Buchwalow I.B., Schulze W., Kostic M.M., Wallukat G., and Morwinski R. Intracellular localization of inducible nitric oxide synthase in neonatal rat cardiomyocytes in culture. Acta Histochem. 99 (1997) 231-240
113. Kacimi R., Long C.S., and Karliner J.S. Chronic hypoxia modulates the interleukin-1-beta-stimulated inducible nitric oxide synthase pathway in cardiac myocytes. Circulation 96 (1997) 1937-1943
114. Rakhit R.D., Edwards R.J., and Marber M.S. Nitric oxide, nitrates and ischaemic preconditioning. Cardiovasc. Res. 43 (1999) 621-627
115. Matoba S., Tatsumi T., Keira N., Kawahara A., Akashi K., Kobara M., et al. Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes. Circulation 99 (1999) 817-822
116. Shimojo T., Hiroe M., Ishiyama S., Ito H., Nishikawa T., and Marumo F. Nitric oxide induces apoptotic death of cardiomyocytes via a cyclic-GMP-dependent pathway. Exp. Cell Res. 247 (1999) 38-47
117. Yao Z., Tong J., Tan X., Li C., Shao Z., Kim W.C., et al. Role of reactive oxygen species in acetylcholine-induced preconditioning in cardiomyocytes. Am. J. Physiol. 277 (1999) H2504-H2509
118. ATP channels. Am. J. Physiol. Heart Circ. Physiol. 279 (2000) H1858-H1863
119. Vanden Hoek T.L., Becker L.B., Shao Z.H., Li C.Q., and Schumacker P.T. Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion. Circ. Res. 86 (2000) 541-548
120. ATP channels and PKC-ε. Am. J. Physiol. Heart Circ. Physiol. 282 (2002) H1380-H1386
121. 2 opens mitochondrial K ATP channels and inhibits GABA receptors via protein kinase C-ε in cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 282 (2002) H1395-H1403
122. Lebuffe G., Schumacker P.T., Shao Z.-H., Anderson T., Iwase H., and Vanden Hoek T.L. ROS and NO trigger early preconditioning. Am. J. Physiol. Heart Circ. Physiol. 284 (2003) H299-H308
123. Bolli R. The late phase of preconditioning. Circ. Res. 87 (2000) 972-983
124. Schulz R., Cohen M.V., Behrends M., Downey J.M., and Heusch G. Signal transduction of ischemic preconditioning. Cardiovasc. Res. 52 (2001) 181-198
125. Maulik N., Watanabe M., Zu Y.-L., Huang C.-K., Cordis G.A., Schley J.A., et al. Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett. 396 (1996) 233-237
126. Martindale J.L., and Holbrook N.J. Cellular response to oxidative stress: Signaling for suicide and survival. J. Cell. Physiol. 192 (2002) 1-15
127. Liberatore C.M., and Yutzey K.E. MAP Kinase activation in avian cardiovascular development. Dev. Dyn. 230 (2004) 773-780
128. Seko Y., Takahashi N., Tobe K., Kadowaki T., and Yazaki Y. Hypoxia and hypoxia/reoxygenation activate p65 PAK, p38mitogen-activated protein kinase (MAPK), and stress-activated protein kinase (SAPK) in cultured rat cardiac myocytes. Biochem. Biophys. Res. Commun. 239 (1997) 840-844
129. Vanden Hoek T.L., Becker L.B., Shao Z., Li C., and Schumacker P.T. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J. Biol. Chem. 273 (1998) 18092-18098
130. Kulisz A., Chen N., Chandel N.S., Shao Z., and Schumacker P.T. Mitochondrial ROS initiate phosphorylation of p38 kinase during hypoxia in cardiomyocytes. Am. J. Physiol. 282 (2002) L1324-L1329
131. Yue Y., Qin Q., Cohen M.V., Downey J.M., and Critz S.D. The relative order of mKATP channels, free radicals and p38 MAPK in preconditioning's protective pathway in rat heart. Cardiovasc. Res. 55 (2002) 681-689
132. Steenbergen C. The role of p38 mitogen-activated protein kinase in myocardial ischemia/reperfusion injury; relationship to ischemic preconditioning. Basic Res. Cardiol. 97 (2002) 276-285
133. Tong H., Chen W., London R.E., Murphy E., and Steenbergen C. Preconditioning enhanced glucose uptake is mediated by p38 MAP kinase not by phosphatidylinositol 3-kinase. J. Biol. Chem. 275 (2000) 11981-11986
134. Hattori R., Maulik N., Otani H., Zhu L., Cordis G., Engelman R.M., et al. Role of STAT3 in ischemic preconditioning. J. Mol. Cell. Cardiol. 33 (2001) 1929-1936
135. Bolli R., Dawn B., and Xuan Y.T. Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury. Trends Cardiovasc. Med. 13 (2003) 72-79
136. Yamaura G., Turoczi T., Yamamoto F., Siddqui M.A.Q., Maulik N., and Das D.K. STAT signaling in ischemic heart: a role of STAT5A in ischemic preconditioning. Am. J. Physiol. Heart Circ. Physiol. 285 (2003) H476-H482
137. Redwood S.R., Ferrari R., and Marber M.S. Myocardial hibernation and stunning: from physiological principles to clinical practice. Heart 80 (1998) 218-222
138. Taegtmeyer H., King L.M., and Jones B.E. Energy substrate metabolism, myocardial ischemia, and targets for pharmacotherapy. Am. J. Cardiol. 82 (1998) 54K-60K
139. Taegtmeyer H., Wilson C.R., Razeghi P., and Sharma S. Metabolic energetics and genetics in the heart. Ann. N. Y. Acad. Sci. 1047 (2005) 208-218
140. Ausma J., Thoné F., Dispersyn G.D., Flameng W., Vanoverschelde J.L., Ramaekers F.C.S., et al. Dedifferentiated cardiomyocytes from chronic hibernating myocardium are ischemia-tolerant. Mol. Cell. Biochem. 186 (1998) 159-168
141. Depre C., Vanoverschelde J.-L., and Taegtmeyer H. Glucose for the heart. Circulation 99 (1999) 578-588
142. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol. Rev. 79 (1999) 215-262
143. Narishige T., Blade K.L., Ishibashi Y., Nagai T., Hamawaki M., Menick D.R., et al. Cardiac hypertrophic and developmental regulation of the beta-tubulin multigene family. J. Biol. Chem. 274 (1999) 9692-9697
144. Purcell I.F., Bing W., and Marston S.B. Functional analysis of human cardiac troponin by the in vitro motility assay: comparison of adult, foetal and failing hearts. Cardiovasc. Res. 43 (1999) 884-891
145. Tardy-Cantalupi I., Montessuit C., Papageorgiou I., Remondino-Müller A., Assimacopoulos-Jeannet F., Morel D.R., et al. Effect of transient ischemia on the expression of glucose transporters GLUT-1 and GLUT-4 in rat myocardium. J. Mol. Cell. Cardiol. 31 (1999) 1143-1155
146. Barker D.J.P. The developmental origins of chronic adult disease. Acta Paediatr. Suppl. 446 (2004) 26-33
147. Lau C., and Rogers J.M. Embryonic and fetal programming of physiological disorders in adulthood. Birth Defects Research 72 (2004) 300-312
148. Louey S., and Thornburg K.L. The prenatal environment and later cardiovascular disease. Early Hum. Dev. 81 (2005) 745-751
149. Bennet L., and Gunn A.J. Memories of the fetal heart. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285 (2003) R517-R518
150. Han H.-C., Austin K.J., Nathanielsz P.W., Ford S.P., Nijland M.J., and Hansen T.R. Maternal nutrient restriction alters gene expression in the ovine fetal heart. J. Physiol. 558 (2004) 111-121
151. Li G.H., Bae S., and Zhang L.B. Effect of prenatal hypoxia on heat stress-mediated cardioprotection in adult rat heart. Am. J. Physiol. Heart Circ. Physiol. 286 (2004) H1712-H1719
152. Broberg C.S., Giraud G.D., Schultz J.M., Thornburg K.L., Hohimer A.R., and Davis L.E. Fetal anemia leads to augmented contractile response to hypoxic stress in adulthood. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285 (2003) R649-R655